Journal Article

VEGFD/VEGFR3 signaling contributes to the dysfunction of the astrocyte IL-3/microglia IL-3Rα cross-talk and drives neuroinflammation in mouse ischemic stroke

Cao, Rui-qi, Schoen, Ingmar, Wang, Shuai, Liu, Yuan, Zhu, Yong-ming, Du, Hua-ping, Zhou, Xian-yong, Guo, Yi, Qiao, Shi-gang, Zhang, Hui-ling, Xu, Yuan, Sun, Lei, Lu, Qi-xia

2025

Overview

Astrocyte-derived IL-3 activates the corresponding receptor IL-3Rα in microglia. This cross-talk between astrocytes and microglia ameliorates the pathology of Alzheimer’s disease in mice. In this study we investigated the role of IL-3/IL-3Rα cross-talk and its regulatory mechanisms in ischemic stroke. Ischemic stroke was induced in mice by intraluminal occlusion of the right middle cerebral artery (MCA) for 60 min followed by reperfusion (I/R). Human astrocytes or microglia subjected to oxygen-glucose deprivation and reoxygenation (OGD/Re) were used as in vitro models of brain ischemia. We showed that both I/R and OGD/Re significantly induced decreases in astrocytic IL-3 and microglial IL-3Rα protein levels, accompanied by pro-inflammatory activation of A1-type astrocytes and M1-type microglia. Importantly, astrocyte-derived VEGFD acting on VEGFR3 of astrocytes and microglia contributed to the cross-talk dysfunction and pro-inflammatory activation of the two glial cells, thereby mediating neuronal cell damage. By using metabolomics and multiple biochemical approaches, we demonstrated that IL-3 supplementation to microglia reversed OGD/Re-induced lipid metabolic reprogramming evidenced by upregulated expression of CPT1A, a rate-limiting enzyme for the mitochondrial β-oxidation, and increased levels of glycerophospholipids, the major components of cellular membranes, causing reduced accumulation of lipid droplets, thus reduced pro-inflammatory activation and necrosis, as well as increased phagocytosis of microglia. Notably, exogenous IL-3 and the VEGFR antagonist axitinib reestablished the cross-talk of IL-3/IL-3Rα, improving microglial lipid metabolic levels via upregulation of CPT1A, restoring microglial phagocytotic function and attenuating microglial pro-inflammatory activation, ultimately contributing to brain recovery from I/R insult. Our results demonstrate that VEGFD/VEGFR3 signaling contributes to the dysfunction of the astrocyte IL-3/microglia IL-3Rα cross-talk and drives pro-inflammatory activation, causing lipid metabolic reprogramming of microglia. These insights suggest VEGFR3 antagonism or restoring IL-3 levels as a potential therapeutic strategy for ischemic stroke.

• Publisher: Springer Nature Singapore,Nature Publishing Group
• Subject: Alzheimer's disease / Animals / Astrocytes / Astrocytes - metabolism / Biomedical and Life Sciences / Biomedicine / Cell membranes / Cells, Cultured / Cerebral blood flow / Glial cells / Glucose / Humans / Immunology / Infarction, Middle Cerebral Artery - metabolism / Infarction, Middle Cerebral Artery - pathology / Inflammation / Interleukin 3 / Interleukin-3 - metabolism / Internal Medicine / Ischemia / Ischemic Stroke - metabolism / Ischemic Stroke - pathology / Lipids / Male / Medical Microbiology / Metabolic rate / Metabolism / Metabolomics / Mice / Mice, Inbred C57BL / Microglia / Microglia - metabolism / Neurodegenerative diseases / Neuroinflammatory Diseases - metabolism / Neuronal-glial interactions / Oxygen / Phagocytosis / Pharmacology/Toxicology / Reperfusion / Signal Transduction / Stroke / Vaccine / Vascular Endothelial Growth Factor Receptor-3 - metabolism / Vascular endothelial growth factor receptors